Onsite Flu Vaccinations
2025 Flu Vaccination Proposal
Home » 2025 Flu Vaccination Proposal » Onsite Flu Vaccinations
Over the past 12 years, AVS has become the market leader in workplace vaccinations across Australia. We will work with you to understand your organisation and develop a program that best suits your employees in order to achieve the highest uptake.
AVS can provide you with various material to help you save administration time whilst promoting the program to your staff and internal stakeholders. This includes materials such as:
- Template emails to send to staff to let them know about the program and how to book/order a voucher
- Template emails to send to office coordinators explaining what they need to do and the requirements of the nurse (i.e. room requirements)
- Posters with QR codes (great for staff members that don’t have access to a computer)
- FAQ Documents
- Information on the vaccination and what to expect on the day
- Product and Consumer Information on the vaccine
Locations AVS serviced with onsite clinics
2025 Influenza Vaccine Strains
The composition for the influenza vaccine for use in the Southern Hemisphere’s influenza season for the 2025 will contain the following:
- an A/Victoria/4897/2022 (H1N1) pdm09-like virus.
- an A/Croatia/10136RV/2023 (H3N2)-like virus.
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
- and B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
There is one change to the Quadrivalent vaccine compared to the Quadrivalent offered in 2024. The Southern Hemisphere 2025 vaccine will contain one new strain for (H3N2) like virus.
The Egg-based quadrivalent influenza vaccines is AVS standardised vaccine for 2024 flu season.